- Home
- DIBS vs NBTX Comparison
DIBS vs NBTX Comparison
Compare DIBS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DIBS | NBTX |
|---|---|---|
| Founded | 2000 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.3M | 1.0B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DIBS | NBTX |
|---|---|---|
| Price | $5.91 | $23.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 292.6K | 37.8K |
| Earning Date | 11-07-2025 | 09-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $89,422,000.00 | $11,930,711.00 |
| Revenue This Year | $3.46 | N/A |
| Revenue Next Year | $2.80 | $145.24 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.49 | N/A |
| 52 Week Low | $2.30 | $2.82 |
| 52 Week High | $6.63 | $30.35 |
Technical Indicators
Market Signals| Indicator | DIBS | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 58.15 |
| Support Level | $5.66 | $21.44 |
| Resistance Level | $5.99 | $24.01 |
| Average True Range (ATR) | 0.27 | 0.87 |
| MACD | -0.10 | 0.07 |
| Stochastic Oscillator | 31.71 | 73.94 |
Price Performance
Historical ComparisonAbout DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.